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Macrophages play a key role in innate immune response to pathogens and in tissue homeostasis,
inﬂammation and repair. A serpin A3G (SpiA3G) is highly induced in classically activated macro-
phages. We show increased localization of SpiA3G in the nucleolus and co-localization with cathep-
sin L, upon classical, but not alternative activation of macrophages. Despite the increased expression
of cathepsin L in the nuclei of classically activated macrophages, no cathepsin activity was detected.
Since only pro-inﬂammatory, but not anti-inﬂammatory stimuli induce increased nucleolar locali-
zation of SpiA3G, we propose that SpiA3g translocation into the nucleolus is important in host
defense against pathogens.
Structured summary:
MINT-7714245: ﬁbrillarin (uniprotkb:P35550) and SpiA3G(uniprotkb:Q5I2A0)co-localize (MI:0403) by
ﬂuorescence microscopy(MI:0416)
MINT-7714241: SpiA3G (uniprotkb:Q5I2A0) and cathepsin L(uniprotkb:P06797) co-localize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction patibility complex (MHC) class II-restricted antigen presentationMacrophages are present in virtually all tissues and play a
critical role in host defense against pathogens and in pathogene-
sis of autoimmune and inﬂammatory diseases [1]. Pathogen rec-
ognition is mediated by the so-called pattern recognition
receptors, many of which belong to the Toll-like receptor family.
Toll-like receptor 4 (TLR4) mediates signals generated by lipo-
polysaccharide (LPS), a major component of the cell walls of
gram-negative microorganisms [2]. In response to LPS, mouse
macrophages undergo a major change in gene expression [3].
Interferon gamma (IFN-c) is produced by the host cells in re-
sponse to intracellular pathogens, and, in combination with the
TLR ligation, leads to the classical activation of macrophages
[4]. Classical activation of macrophages leads to increased intra-
cellular resistance to microbes and to increased major histocom-chemical Societies. Published by E
c, interferon gamma; IL-4,
histocompatibility complex;
age-speciﬁc protein; SpiA3G,
ment of Biochemistry Molec-
Jamova 39, 1000 Ljubljana,
rala).[5,6]. An initial exposure of cells to a low level of LPS preceding
an exposure to a higher level of LPS induces a transient state of
cell refractoriness, a phenomenon known as ‘‘endotoxin toler-
ance” [7]. Induction of tolerance is thought to protect the host
from cellular damage caused by hyperactivation of macrophages
and other immune cells and likely represents a means of immune
cell adaptation to a persistent bacterial infection [8]. Activated
macrophages secrete also high levels of pro-inﬂammatory cyto-
kines and mediators [9]. Alternatively activated macrophages de-
velop in response to interleukin-4 (IL-4) released by basophiles
and mast cells [10]. IL-4 stimulation converts macrophages into
a population of cells that are programmed to promote wound
healing and down regulate inﬂammation [4,10].
Upon the activation with IFN-c and LPS macrophages up-regu-
late a variety of proteases that can degrade endocytosed pathogens
and express higher levels of surface MHC class II molecules that
can present the resulting pathogen peptides to the T cells [11]. A
critical role in antigen processing and in the formation of pep-
tide-receptive dimers during MHC class II-restricted antigen pre-
sentation play the endosomal cathepsins [12]. The activities of
cysteine cathepsins are efﬁciently inhibited by their endogenous
protein inhibitors cystatins [13,14], thyropins [15], and some of
the serpins [16–19]. Among the cathepsin-inhibiting serpins,lsevier B.V. All rights reserved.
2202 Š. Konjar et al. / FEBS Letters 584 (2010) 2201–2206serpin A3G (also called Spi2A), was ﬁst described in mouse hema-
topoietic progenitor cells and activated T cells [20]. In mouse ﬁbro-
blasts, induction of SpiA3G expression by NF-jB extinguished
cathepsin B activity in the cytosol and protected cells from the
classical caspase-dependent apoptosis and caspase-independent
apoptosis [21,22]. It was reported that SpiA3G is up-regulated in
memory cell precursors and promotes the survival of CD8+ cyto-
toxic T lymphocytes, allowing them to differentiate into memory
CD8+ T cells [23]. SpiA3G is also highly up-regulated in IFN-c and
LPS stimulated macrophages [24].
Initially, the aim of our work was to determine if up-regulation
of SpiA3G in activated macrophages results in the inhibition of
endosomal cysteine cathepsin activity. However, in classically acti-
vated macrophages, as well as upon induction of experimental
endotoxin tolerance, SpiA3G did not co-localize with cysteine
cathepsins in the endolysososmes. Here, we show for the ﬁrst time
increased localization of SpiA3G in the nucleus upon the activation
of macrophages with IFN-c and LPS. Detailed examination revealed
that SpiA3G was co-localized with ﬁbrillarin in the nucleolus of
RAW 264.7 mouse macrophages. SpiA3G was found to be co-local-
ized with cathepsin L. These results provide the ﬁrst indication that
SpiA3G might regulate cathepsin L activity in the nuclei of acti-
vated macrophages.SpiA3G
Actin
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Fig. 1. SpiA3G is up-regulated upon the activation of RAW 264.7 macrophages, but
not upon the induction of endotoxin tolerance or IL-4 treatment. Lane 1: Untreated
cells (control); lane 2: IFN-c (300 UI); lane 3: IFN-c (300 UI) and LPS (100 ng/ml);
lane 4: LPS (100 ng/ml); lane 5: LPS (2 ng/ml) 48 h primed/LPS (100 ng/ml) 18 h;
lane 6: IL-4 primed (100 UI/ml). Fifty micrograms of total cell lysates were loaded.
Actin was used as a loading control.2. Materials and methods
2.1. Antibodies and other reagents
Anti-cathepsin L mouse monoclonal antibody N135 was de-
scribed previously [25]. Rabbit polyclonal antibodies against re-
combinant mouse cathepsin L were prepared by the standard
immunization procedure [26]. Polyclonal anti-SpiA3G (Spi2A) anti-
bodies (Cat.no. AP1022) were from Calbiochem (San Diego, CA) and
a gift form P. Coughlin. Anti-ﬁbrillarin antibody [38F3] (Ab4566)
and anti-c-Jun [E254], Jun antibody (ab32173) were from Abcam.
Anti-Horseradish peroxidase-conjugated goat-anti-rabbit IgG anti-
bodies, fetal calf serum (FCS), were obtained from Sigma (USA).
Mouse Interferon-gamma was from Abazyme (Cat:CTK-358 ;
Needham, MA), and LPS (O55:B5) was from Sigma–Aldrich (Saint
Louis, MO).
2.2. Cell culture
RAW 264.7 macrophages (American Type Culture Collection
(ATCC), Manassas VA) were cultured in DMEM (BioWhittaker, Gai-
thersburg, MD) with 10% FCS (HyClone Laboratories, Logan, UT),
2 mM glutamine (Life Technologies, Gaithersburg, MD), and
1000 U/ml of penicillin–streptomycin at 37 C and 5% CO2.
2.3. Preparation of cell lysates
Cell lysates were prepared as described [27]. Nuclear extracts
were prepared by the method of Dignam et al. [28] with minor
modiﬁcations, including the use of a protease inhibitor cocktail
(Cat.No.P8340; Sigma–Aldrich) and the addition of phenylmethyl-
sulfonyl ﬂuoride (PMSF; Fluka Basel, Switzerland) (0.5 mM) to the
resuspension and lysis buffers. The supernatants were transferred
to fresh test tubes and, if not used immediately, stored at 80 C.
Total protein concentration was determined using the Bradford as-
say (Bio-Rad, USA).
2.4. Active site labeling of cysteine proteinases
Active site labeling experiments of cysteine proteinases were
performed as previously described [29]. RAW 264.7 cells under dif-ferent stimulations were labeled with 1 lM GB123 activity-based
probes (ABP) in culture medium for 3 h at at 37 C and 5% CO2. Cells
were washed with cold 1XPBS. Nuclear and postnuclear lysates
were prepared as described above without addition of the protease
inhibitor cocktail. Equal amounts of protein per lane were sepa-
rated by 12.5% SDS–PAGE, and labeled proteases were visualized
by scanning of the gel with a Typhoon ﬂatbed laser scanner (Ex/
Em 532/580 nm).
2.5. Confocal microscopy
RAW 264.7 macrophages grown on cover slides, were ﬁxed with
4% paraformaldehyde in PBS (pH 7.2) for 10 min and permeabilized
with 0.1% Triton X-100 for an additional 5 min. Cathepsin L was la-
beled with mouse anti-cathepsin L monoclonal antibody N135 [25]
and SpiA3G with polyclonal rabbit antibodies (Calbiochem). Fluo-
rescence microscopy was performed using Carl Zeiss LSM 510 con-
focal microscope. Alexa Fluor 488 or Alexa Fluor 546 and
rhodamine were excited with an argon (488 nm) or He/Ne
(543 nm) laser and emission was ﬁltered using a narrow band LP
505-530 nm (green ﬂuorescence) and 560 nm (red ﬂuorescence)
ﬁlter, respectively. Carl Zeiss LSM image software 3.0 (Correlation
Plots) was used to evaluate co-localization between the two la-
beled proteins (i.e., between red and green ﬂuorescence signals).
3. Results and discussion
3.1. SpiA3G is up-regulated in activated macrophages, but not upon
the induction of experimental endotoxin tolerance or IL-4 treatment
LPS is a potent and physiologically relevant activator of macro-
phages. Our results conﬁrm previous observations that the expres-
sion of SpiA3G is up-regulated upon IFN-c and LPS treatment [24].
We have further investigated the expression of SpiA3G upon the
induction of experimental endotoxin tolerance and activation of
macrophages with IL-4. RAW 264.7 mouse macrophages were trea-
ted with IFN-c, LPS and IL-4, experimental endotoxin tolerance
was induced as described previously [8]. In total cell lysates, the
levels of SpiA3G were found to be up-regulated in the activated
macrophages, however, upon the induction of experimental endo-
toxin tolerance and IL-4 treatment the protein levels of SpiA3G
were comparable to the levels in untreated cells (Fig. 1). Recently,
several DNA microarrays studies revealed the effects of pathogens
on host-cell gene expression programs in great depth and on a
broad scale [3,30]. However, only little is known whether up-regu-
lation of the speciﬁc gene expression resulted also in different
localization and interactions in the cell. Greiner et al. examined
the activity and distribution of cysteine cathepsins in un
stimulated monocytes by subcellular fractionation and the use of
ABP. Active cathepsins B, H and S were found preferentially in
the lysosomal fraction, while a signiﬁcant amount of active cathep-
sin S and very little active cathepsin B and H were found in the late
Fig. 2. LPS and IFN-c synergistically induced changes in the localization of SpiA3G in RAW 264.7 macrophages. Cells left unstimulated (A), or were primed overnight with
300 UI/ml IFN-c and treated with 100 ng/ml LPS for 18 h (B) or primed with 100 UI/ml IL-4. After indicated treatments, cells were stained with propidium iodide (PI) (red),
ﬁxed and labeled with SpiA3G antibodies and Alexa ﬂuor 488 secondary antibodies (green). (D) SpiA3G co localizes with nucleolar marker ﬁbrillarin. Cells were primed
overnight with 300 UI/ml IFN-c and treated with 100 ng/ml LPS for 18 h, ﬁxed and labelled with mouse anti ﬁbrillarin antibodies and Alexa ﬂuor 546 secondary antibodies
(red), and withSpiA3G antibodies and Alexa ﬂuor 488 secondary antibodies (green). Nucleoli were visualized also by differential interference contrast (DIC) microscopy.
Arrows indicate the position of the nuceoli. Scale bar: 10 lm.
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human monocytes resulted not only in an up-regulation of cathep-
sins activity but also in differential changes in cathepsin B, L and
distribution in endosomes, lysosomes and whole cells [32].
3.2. LPS and IFN-c synergistically induced changes in the localization
of spiA3G
LPS and IFN-c, which both up-regulate SpiA3G mRNA, also up-
regulate expression of several other genes in macrophages [3]. We
examined whether the treatment of RAW 264.7 macrophages with
these pro-inﬂammatory agents provokes changes in the SpiA3G
localization. The classical activation of RAW 264.7 macrophages
was conﬁrmed by quantiﬁcation of NO production, using Griess re-
agent, as described in Supplementary data (Fig. S1). In RAW 264.7
cells stimulated with IFN-c and LPS, SpiA3G did not co-localize
with endosomal/ lysosomal marker Lamp1 (data not shown). In-
stead, macrophages activated by sequential treatment with IFN-c
and LPS, induced a relocation of the SpiA3G protein into the nu-
cleus (Fig. 2B). In contrast, in unstimulated RAW 264.7 cells and
in IL-4 stimulated RAW 264.7 cells very little SpiA3G was observed
in the nucleus (Fig. 2A and C). Although nuclear localization of
SpiA3G was reported more than a decade ago, its function in the
nucleus has not been elucidated yet [20]. For several intracellular
serpins proteinase inhibitor (PI)-9, PI-6, monocyte neutrophil elas-
tase inhibitor (MNEI), PI-8, plasminogen activator inhibitor 2 (PAI-
2) nuclear and cytoplasmic localizations were reported [33].
Although the mechanism of nucleocytoplasmic transport was de-
scribed for the PI-9 [33], the signal that triggers this translocation
has not been elucidated yet. We have shown that during classical
activation of macrophages, that leads to development of pro-
inﬂammatory (M1) phenotype, SpiA3G is not only up-regulated
by also translocated into the nucleus (Fig. 2B). Using speciﬁc anti-
bodies to nucleolar protein ﬁbrillarin we conﬁrmed localization of
SpiA3G in the nucleolus (Fig. 2D). Nucleolar morphology was con-
ﬁrmed also with differential interference contrast (DIC) micros-
copy (Fig. 2D). The nucleolus is a dynamic nuclear structure
involved in ribosome subunit biogenesis and mediating responses
to cell stress [34,35]. The precise function of SpiA3G in the nucleo-
lus in M1 activated macrophages is not clear yet.Fig. 3. Double labeling confocal immunoﬂuorescent analysis for co-localization of SpiA3G
(A), or were primed overnight with 300 UI/ml IFN-c and treated with 100 ng/ml LPS fo
(red) and SpiA3G (green) were co-localized in the nucleoli of RAW 264.7 macrophages.3.3. SpiA3G co-localizes with cathepsin L in the nucleoli of activated
macrophages
In the next step we aimed at identifying the possible target(s) of
SpiA3G in the nucleoli of activated macrophages, as SpiA3G was
shown to inhibit not only cathepsin B and prevent apoptosis in-
duced by cathepsin B leaking from the lysosomes, but was also
shown to inhibit cathepsin L in vitro [21]. In order to evaluate pos-
sible roles of SpiA3G in the nucleus we examined the co-localiza-
tion of SpiA3G with cathepsin L in the nucleolus. Cathepsin L and
SpiA3G partially co-localized in the nucleoli of RAW 264.7 cells
primed with IFN-c and stimulated with LPS (Fig. 3B), but not in
unstimulated cells (Fig. 3A). Recently, three independent reports
described the activity of otherwise endosomal proteinase cathep-
sin L in the nucleus. Cathepsin L was reported to process the
CUX1 transcription factor and consequently inﬂuenced the cell cy-
cle progression [36]. It was shown that cathepsin L deﬁciency
causes a global rearrangement of the chromatin structure [37].
Cathepsin L cleaved histone H3.2 in the nucleus and the cleavage
was relevant for the development and differentiation of mouse
stem cells [38].
3.4. Increased expression of cathepsin L in the nucleus in activated
RAW 264.7 macrophages did not correlate with increased activity
An increased cathepsin L expression was detected in IFN-c
primed of and LPS stimulated postnuclear cell lysates (Fig. 4A)
and nuclear lysates of (Fig. 4B). Activity-based probes (ABP) can
be used for monitoring enzyme activity based on their covalent
reactions with active-site residues. Structure and speciﬁcity of GB
123 and GB 137 active site probes were reported before [39]. Most
of the cathepsin activity in post-nuclear lysates of the RAW 264.7
macrophages could be attributed to cathepsin S, B and L activities
(Fig. 5), while in the nuclear lysates of IFN-c and LPS stimulated
cells cathepsin activity could not be detected with GB 123 nor with
GB 137 probe (data not shown). The myeloid and erythroid nuclear
termination stage-speciﬁc protein, MENT, was the ﬁrst known
chromatin-associated cysteine proteinase inhibitor that interacts
with chromatin and inﬂuence heterochromatin distribution
[40,41]. MENT, a serpin that also inhibits cathepsin L, stronglyand cathepsin L in the nucleoli of RAW 264.7 macrophages. Cells left unstimulated
r 18 h (B). Double-labeling immunoﬂourescent data demonstrated that cathepsin L
Arrows indicate colocalization of SpiA3G and cathepsin L. Scale bar: 10 lm.
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Fig. 4. Cathepsin L was up-regulated in the nuclei in response to IFN-c and LPS.
Lane 1: RAW 264.7 cells were left untreated; lane 2: primed overnight with IFN-c
(300 Ul/ml); lane 3: treated with LPS alone; lane 4: primed overnight with IFN-c
(300 UI/ml), and treated with LPS (100 ng/ml) for 24 h. Post nuclear (A) and nuclear
(B) protein extracts were analyzed by Western blotting using anti cathepsin L
polyclonal antibody. Hundred micrograms of nuclear cell and 50 lg of post nuclear
cell lysates were loaded. Actin and c-Jun were used as loading controls.
Fig. 5. Cathepsin activities in RAW 264.7 macrophages. RAW 264.7 cells under
different stimulations were labeled with 1 lM GB123 ABP in culture medium for
3 h. Post nuclear lysates were analyzed for cathepsin activities on 12.5% SDS–PAGE
and visualized by scanning of the gel with a Typhoon ﬂatbed laser scanner. Lane 1:
RAW 264.7 cells were left untreated; lane 2: treated with LPS (100 ng/ml); lane 3:
treated with IFN-c (300 UI/ml); lane 4: primed overnight with IFN-c (300 UI/ml),
and treated with LPS (100 ng/ml) for 24 h. M, ﬂuorescent marker.
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[41]. It was shown that nuclear cathepsin L stimulates the reloca-
tion of MENT away from heterochromatin, its subsequent associa-
tion with euchromatin [41]. Recently, we have shown that the
nuclear cystatin, steﬁn B, regulates cathepsin L activity in the nu-
cleus [42]. Although it is tempting to speculate that SpiA3G inhib-
its cathepsin L activity in the nucleus, additional studies will be
needed to conﬁrm (or reject) this hypothesis. We have conﬁrmed
not only increased localization of cathepsin L into the nucleus of
activated macrophages (Fig. 4B), but also its co-localization with
SpiA3G in the nucleolus (Fig. 2D). Since only the pro-inﬂammatory
stimuli (IFN-c and LPS) and not the anti-inﬂammatory stimuli (IL-
4) induce increased nucleolar localization of SpiA3G, we propose
that SpiA3G functions in the nucleolus are important for the host
defense against pathogens. SpiA3G is mouse speciﬁc serpin and a
human homologue has not been described so far, therefore it isnot clear which protein compensates for SpiA3G deﬁciency in hu-
man macrophages.
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